Last reviewed · How we verify
DSP-1349M
At a glance
| Generic name | DSP-1349M |
|---|---|
| Also known as | lurasidone |
| Sponsor | Sumitomo Pharma America, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DSP-1349M CI brief — competitive landscape report
- DSP-1349M updates RSS · CI watch RSS
- Sumitomo Pharma America, Inc. portfolio CI